Science Translational Medicine,
Journal Year:
2023,
Volume and Issue:
15(716)
Published: Oct. 4, 2023
Hyperexcitability
in
sensory
neurons
is
known
to
underlie
many
of
the
maladaptive
changes
associated
with
persistent
pain.
Chemogenetics
has
shown
promise
as
a
means
suppress
such
excitability,
yet
chemogenetic
approaches
suitable
for
human
applications
are
needed.
PSAM
4
-GlyR
modular
system
based
on
α7
nicotinic
acetylcholine
and
glycine
receptors,
which
responds
inert
chemical
ligands
clinically
approved
drug
varenicline.
Here,
we
demonstrated
efficacy
this
channel
silencing
both
mouse
by
activation
large
shunting
conductances
after
agonist
administration.
Virally
mediated
expression
produced
behavioral
hyposensitivity
upon
administration,
was
recovered
washout.
Stable
led
similar
reversible
suppression
pain-related
behavior
even
10
months
viral
delivery.
Mechanical
spontaneous
pain
readouts
were
also
ameliorated
acute
joint
inflammation
models.
Furthermore,
mechanical
hypersensitivity
generated
spared
nerve
injury
model
neuropathic
observed
channel.
Effective
reproduced
hyperexcitability
clinical
pain:
decreased
excitability
human-induced
pluripotent
stem
cell–derived
activity
due
gain-of-function
Na
V
1.7
mutation
causing
inherited
erythromelalgia.
Our
results
demonstrate
contribution
neuron
translational
potential
an
effective,
stable,
humanized
treatment
Science Translational Medicine,
Journal Year:
2022,
Volume and Issue:
14(632)
Published: Feb. 16, 2022
Nociceptors
are
specialized
sensory
neurons
that
detect
damaging
or
potentially
stimuli
and
found
in
the
dorsal
root
ganglia
(DRG)
trigeminal
ganglia.
These
critical
for
generation
of
neuronal
signals
ultimately
create
perception
pain.
also
primary
targets
treating
acute
chronic
Single-cell
transcriptomics
on
mouse
nociceptors
has
transformed
our
understanding
pain
mechanisms.
We
sought
to
generate
equivalent
information
human
with
goal
identifying
transcriptomic
signatures
nociceptors,
species
differences
potential
drug
targets.
used
spatial
molecularly
characterize
transcriptomes
single
DRG
from
eight
organ
donors.
identified
12
clusters
neurons,
5
which
C
as
well
1
low-threshold
mechanoreceptors
(LTMRs),
Aβ
nociceptor,
2
Aδ,
Aβ,
proprioceptor
subtypes.
By
focusing
expression
profiles
ion
channels,
G
protein-coupled
receptors
(GPCRs),
other
pharmacological
targets,
we
provided
a
rich
map
direct
comparison
neuron
transcriptomes.
compared
subtypes
nonhuman
primates
showing
conserved
patterns
gene
among
many
cell
types
but
divergence
specific
nociceptor
subsets.
Last,
sex
subpopulation
transcriptomes,
including
marked
increase
calcitonin-related
polypeptide
alpha
(CALCA)
female
pruritogen
receptor-enriched
nociceptors.
This
comprehensive
characterization
might
open
door
development
better
treatments
disorders.
Brain,
Journal Year:
2022,
Volume and Issue:
146(2), P. 749 - 766
Published: July 22, 2022
Neuropathic
pain
is
a
leading
cause
of
high-impact
pain,
often
disabling
and
poorly
managed
by
current
therapeutics.
Here
we
focused
on
unique
group
neuropathic
patients
undergoing
thoracic
vertebrectomy
where
the
dorsal
root
ganglia
removed
as
part
surgery
allowing
for
molecular
characterization
identification
mechanistic
drivers
independently
preclinical
models.
Our
goal
was
to
quantify
whole
transcriptome
RNA
abundances
using
RNA-seq
in
pain-associated
human
from
these
patients,
comprehensive
changes
samples
contrasting
them
with
non-pain-associated
ganglia.
We
sequenced
70
ganglia,
among
50
met
inclusion
criteria
sufficient
neuronal
mRNA
signal
downstream
analysis.
expression
analysis
revealed
profound
sex
differences
differentially
expressed
genes
including
increase
IL1B,
TNF,
CXCL14
OSM
male
CCL1,
CCL21,
PENK
TLR3
female
associated
pain.
Coexpression
modules
enrichment
members
JUN-FOS
signalling
males
centromere
protein
coding
females.
Neuro-immune
pathways
distinct
cytokine
(OSM,
LIF,
SOCS1)
females
(CCL1,
CCL19,
CCL21).
validated
cellular
profiles
subset
findings
RNAscope
situ
hybridization.
give
direct
support
underlying
mechanisms
patient
populations.
Science Advances,
Journal Year:
2025,
Volume and Issue:
11(5)
Published: Jan. 31, 2025
Proprioceptors
are
primary
mechanosensory
neurons
to
monitor
the
status
of
muscle
contraction
and/or
body
position
(
1
).
Although
proprioceptors
known
as
non-nociceptive
mechanoreceptors,
they
also
express
pro-nociceptive
acid-sensing
ion
channel
3
(ASIC3)
2
–
5
To
probe
role
for
in
sensing
acidosis
(or
sngception)
6
),
we
found
that
genetic
deletion
Asic3
but
not
nociceptors
abolished
acid-induced
chronic
hyperalgesia
mice.
Chemo-optogenetically
activating
resulted
hyperalgesic
priming
favored
pain
induced
by
acidosis.
In
humans,
intramuscular
acidification
acid
perception
pain.
Conversely,
a
spinal
cord–injured
patient
who
lost
sensation
right
leg,
proprioception
and
sngception
were
remaining
somatosensory
functions,
associated
with
dorsal
column.
Together,
evidence
from
both
mouse
human
studies
suggests
sngception.
Frontiers in Pain Research,
Journal Year:
2021,
Volume and Issue:
2
Published: Dec. 13, 2021
The
persistence
of
increased
excitability
and
spontaneous
activity
in
injured
peripheral
neurons
is
imperative
for
the
development
many
forms
neuropathic
pain.
This
aberrant
involves
and/or
expression
voltage-gated
Na
Stem Cell Reports,
Journal Year:
2023,
Volume and Issue:
18(4), P. 1030 - 1047
Published: April 1, 2023
Development
of
new
non-addictive
analgesics
requires
advanced
strategies
to
differentiate
human
pluripotent
stem
cells
(hPSCs)
into
relevant
cell
types.
Following
principles
developmental
biology
and
translational
applicability,
here
we
developed
an
efficient
stepwise
differentiation
method
for
peptidergic
non-peptidergic
nociceptors.
By
modulating
specific
signaling
pathways,
hPSCs
were
first
converted
SOX10
European Journal of Pain,
Journal Year:
2023,
Volume and Issue:
27(9), P. 1084 - 1098
Published: April 28, 2023
Abstract
Background
The
treatment
of
neuropathic
pain
remains
a
major
unmet
need
that
the
development
personalized
and
refined
strategies
may
contribute
to
address.
Database
In
this
narrative
review,
we
summarize
various
approaches
based
on
objective
biomarkers
or
clinical
markers
could
be
used.
Results
principle,
validation
would
most
robust
approach.
However,
although
promising
results
have
been
reported
demonstrating
potential
value
genomics,
anatomical
functional
markers,
these
has
only
just
begun.
Thus,
documented
date
markers.
particular,
many
studies
suggested
identification
specific
subgroups
patients
presenting
with
combinations
symptoms
signs
relevant
Two
main
used
identify
sensory
profiles:
quantitative
testing
outcomes
description
qualities.
Conclusion
We
discuss
here
advantages
limitations
approaches,
which
are
not
mutually
exclusive.
Significance
Recent
data
indicate
new
predictive
biological
and/or
helpful
better
therefore
improve
management
pain.